{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:53:16Z","timestamp":1791312796340,"version":"4.3.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2006.12.037","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T00:02:16Z","timestamp":1167955336000},"page":"2787-2799","source":"Crossref","is-referenced-by-count":74,"title":["Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges"],"prefix":"10.1016","volume":"25","author":[{"given":"Christiana N.","family":"Fogg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Americo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Damon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Earl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Klinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.12.037_bib1","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2006.12.037_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin Inf Dis"},{"issue":"February (5406)","key":"10.1016\/j.vaccine.2006.12.037_bib3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.283.5406.1279","article-title":"The looming threat of bioterrorism","volume":"283","author":"Henderson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.12.037_bib4","series-title":"Fields virology","first-page":"2849","article-title":"Poxviridae: the viruses and their replication","author":"Moss","year":"2001"},{"key":"10.1016\/j.vaccine.2006.12.037_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/oxfordjournals.aje.a121360","article-title":"The nature of the immune state produced by inactivated vaccinia virus in rabbits","volume":"94","author":"Boulter","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib6","first-page":"86","article-title":"Differences between extracellular and intracellular forms of poxvirus and their implications","volume":"16","author":"Boulter","year":"1973","journal-title":"Prog Med Virol"},{"issue":"April (Pt 4)","key":"10.1016\/j.vaccine.2006.12.037_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1099\/vir.0.80660-0","article-title":"An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model","volume":"86","author":"Law","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-50-1-89","article-title":"Significance of extracellular virus in the in vitro and in vivo dissemination of vaccinia virus","volume":"50","author":"Payne","year":"1980","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.12.037_bib9","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.66.7.4170-4179.1992","article-title":"Role of cell-associated enveloped vaccinia virus in cell-to-cell spread","volume":"66","author":"Blasco","year":"1992","journal-title":"J Virol"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2006.12.037_bib10","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2006.12.037_bib11","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2006.12.037_bib12","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/JVI.65.10.5631-5635.1991","article-title":"The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals","volume":"65","author":"Lai","year":"1991","journal-title":"J Virol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2006.12.037_bib13","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.037_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2006.12.037_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.virol.2005.09.056","article-title":"Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host","volume":"345","author":"Fang","year":"2006","journal-title":"Virology"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2006.12.037_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2006.12.037_bib17","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib18","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J Virol"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2006.12.037_bib19","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2006.12.037_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/bcmd.1998.0201","article-title":"Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region","volume":"24","author":"Poltorak","year":"1998","journal-title":"Blood Cells Mol Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2006.12.037_bib21","first-page":"2654","article-title":"Isolation of a nontoxic lipid A fraction containing tumor regression activity","volume":"41","author":"Takayama","year":"1981","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.037_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0192-0561(86)90116-5","article-title":"Immunobiological activities of nontoxic lipid A: enhancement of nonspecific resistance in combination with trehalose dimycolate against viral infection and adjuvant effects","volume":"8","author":"Masihi","year":"1986","journal-title":"Int J Immunopharmacol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2006.12.037_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1586\/14760584.2.2.219","article-title":"Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529","volume":"2","author":"Evans","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2006.12.037_bib24","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/S0264-410X(02)00209-8","article-title":"QS-21 structure\/function studies: effect of acylation on adjuvant activity","volume":"20","author":"Liu","year":"2002","journal-title":"Vaccine"},{"issue":"February (15\u201316)","key":"10.1016\/j.vaccine.2006.12.037_bib25","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/S0264-410X(00)00415-1","article-title":"QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans","volume":"19","author":"Evans","year":"2001","journal-title":"Vaccine"},{"issue":"November (14)","key":"10.1016\/j.vaccine.2006.12.037_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0264-410X(94)80052-2","article-title":"Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma","volume":"12","author":"Livingston","year":"1994","journal-title":"Vaccine"},{"issue":"May (17\u201318)","key":"10.1016\/j.vaccine.2006.12.037_bib27","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0264-410X(02)00115-9","article-title":"Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21","volume":"20","author":"Kashala","year":"2002","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2006.12.037_bib28","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (6522)","key":"10.1016\/j.vaccine.2006.12.037_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.037_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1348-0421.1992.tb02102.x","article-title":"DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth","volume":"36","author":"Yamamoto","year":"1992","journal-title":"Microbiol Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2006.12.037_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib32","series-title":"NATO Advanced Study Institute on Immunological Adjuvants and Vaccines","first-page":"35","article-title":"Aluminium salts: perspectives in their use as adjuvants","author":"Bomford","year":"1988"},{"issue":"June (5678)","key":"10.1016\/j.vaccine.2006.12.037_bib33","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1089926","article-title":"Promotion of B cell immune responses via an alum-induced myeloid cell population","volume":"304","author":"Jordan","year":"2004","journal-title":"Science"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2006.12.037_bib34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.037_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/0022-1317-1-3-399","article-title":"Respiratory infection of mice with vaccinia virus","volume":"1","author":"Turner","year":"1967","journal-title":"J Gen Virol"},{"issue":"November","key":"10.1016\/j.vaccine.2006.12.037_bib36","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1099\/0022-1317-71-11-2761","article-title":"Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route","volume":"71","author":"Williamson","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2006.12.037_bib38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.146.1.113","article-title":"Intracellular localization of proteasomal degradation of a viral antigen","volume":"146","author":"Anton","year":"1999","journal-title":"J Cell Biol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2006.12.037_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ni762","article-title":"Visualizing priming of virus-specific CD8(+) T cells by infected dendritic cells in vivo","volume":"3","author":"Norbury","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib40","series-title":"Current protocols in molecular biology","first-page":"16.16.1","article-title":"Preparation of cell cultures and vaccinia virus stocks","author":"Earl","year":"1998"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2006.12.037_bib41","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.037_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2006.12.037_bib43","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.77.19.10684-10688.2003","article-title":"Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein","volume":"77","author":"Earl","year":"2003","journal-title":"J Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2006.12.037_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200523220","article-title":"Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction","volume":"115","author":"Yang","year":"2005","journal-title":"J Clin Invest"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2006.12.037_bib45","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0197-2456(01)00158-1","article-title":"Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods","volume":"22","author":"Journot","year":"2001","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2006.12.037_bib46","first-page":"65","article-title":"A simple sequentialrejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2006.12.037_bib47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2005.06.049","article-title":"Bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread","volume":"341","author":"Luker","year":"2005","journal-title":"Virology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2006.12.037_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.antiviral.2004.10.004","article-title":"CpG-DNA protects against a lethal orthopoxvirus infection in a murine model","volume":"65","author":"Rees","year":"2005","journal-title":"Antiviral Res"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2006.12.037_bib49","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2006.12.037_bib50","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice","volume":"172","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.12.037_bib51","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Nat Acad Sci USA"},{"issue":"September (36)","key":"10.1016\/j.vaccine.2006.12.037_bib52","doi-asserted-by":"crossref","first-page":"12921","DOI":"10.1073\/pnas.0505180102","article-title":"Interferon function is not required for recovery from a secondary poxvirus infection","volume":"102","author":"Panchanathan","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2006.12.037_bib53","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2006.12.037_bib54","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.164.10.5167","article-title":"Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production","volume":"164","author":"Mikloska","year":"2000","journal-title":"J Immunol"},{"issue":"June (20\u201321)","key":"10.1016\/j.vaccine.2006.12.037_bib55","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/S0264-410X(99)00062-6","article-title":"The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1","volume":"17","author":"Moore","year":"1999","journal-title":"Vaccine"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2006.12.037_bib56","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.4049\/jimmunol.148.8.2357","article-title":"Saponin adjuvant induction of ovalbumin-specific CD8+cytotoxic T lymphocyte responses","volume":"148","author":"Newman","year":"1992","journal-title":"J Immunol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2006.12.037_bib57","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.148.5.1519","article-title":"Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine","volume":"148","author":"Wu","year":"1992","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2006.12.037_bib58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/aid.1994.10.853","article-title":"Induction of antigen-specific killer T lymphocyte responses using subunit SIVmac251 gag and env vaccines containing QS-21 saponin adjuvant","volume":"10","author":"Newman","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2006.12.037_bib59","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.160.2.870","article-title":"CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen","volume":"160","author":"Davis","year":"1998","journal-title":"J Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2006.12.037_bib60","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1128\/JVI.73.5.4120-4126.1999","article-title":"CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines","volume":"73","author":"Oxenius","year":"1999","journal-title":"J Virol"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2006.12.037_bib61","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.037_bib62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/JVI.75.2.645-653.2001","article-title":"Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140","volume":"75","author":"Earl","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.037_bib63","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:15:48Z","timestamp":1683706548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06013673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":63,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X06013673"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}